Interchangeable Exclusivity: Pfizer To Rival Boehringer On Humira Biosimilar After US FDA Decision

 
• By David Wallace
Hourglass timer dissolving, end of time period concept
The FDA decision has ended Boehringer’s exclusivity period • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics